Major Financial Updates Expected From SSE AstraZeneca and Walt Disney This Week

Market observers are keenly awaiting SSE’s interim results this Wednesday, with particular focus on the FTSE 100 energy group’s spending strategies. The company, a dominant force in UK offshore wind development, has recently achieved significant milestones including the completion of its 443-megawatt Viking onshore wind farm and the crucial Shetland subsea link.

SSE’s Dogger Bank A project remains under scrutiny after experiencing additional delays, pushing completion to the latter half of 2025. The wind farm, part of a larger complex designed to deliver 3.6 gigawatts of power, represents a critical component of the UK’s renewable energy infrastructure.

AstraZeneca faces heightened attention during tomorrow’s third-quarter trading update, primarily due to ongoing investigations in China, a market representing 13% of its sales. The pharmaceutical giant has moved to reassure investors by reaffirming its $80 billion 2030 group revenue target, though market sentiment remains cautious following recent share price volatility.

Babcock International’s Wednesday update is expected to show continued progress under Chief Executive David Lockwood’s leadership, despite earlier challenges including increased losses on the Type 31 frigate programme. The defence contractor maintains its trajectory toward a £300 million annual profit target.

Walt Disney’s fourth-quarter results, scheduled for Thursday, are projected to show revenues of £22.6 billion, marking a 6.4% year-on-year increase. The entertainment conglomerate’s streaming division’s performance will be closely monitored, following its first profitable period reported in August.

WH Smith rounds off the week’s major updates, with analysts forecasting pre-tax profits of £166 million for the year ending August, substantially higher than the previous year’s £110 million. The retailer’s travel division has demonstrated robust performance, reporting a 12% increase in annual sales.

Post Disclaimer

The following content has been published by Stockmark.IT. All information utilised in the creation of this communication has been gathered from publicly available sources that we consider reliable. Nevertheless, we cannot guarantee the accuracy or completeness of this communication.

This communication is intended solely for informational purposes and should not be construed as an offer, recommendation, solicitation, inducement, or invitation by or on behalf of the Company or any affiliates to engage in any investment activities. The opinions and views expressed by the authors are their own and do not necessarily reflect those of the Company, its affiliates, or any other third party.

The services and products mentioned in this communication may not be suitable for all recipients, by continuing to read this website and its content you agree to the terms of this disclaimer.